StubHub Holdings, Inc. (STUB) Class Action Lawsuit Deadline Approaches on January 23, 2026
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 19 2026
0mins
Should l Buy STUB?
Source: Globenewswire
- Lawsuit Background: Rosen Law Firm reminds purchasers of StubHub (NYSE: STUB) stock regarding a class action lawsuit filed against the Registration Statement from the September 2025 IPO, with a lead plaintiff application deadline of January 23, 2026, necessitating prompt action from investors to protect their rights.
- Potential Compensation: Investors participating in the class action may receive compensation without any upfront costs through a contingency fee arrangement, aimed at alleviating financial burdens and encouraging more affected individuals to join the lawsuit.
- False Statement Allegations: The lawsuit alleges that StubHub's Registration Statement contained materially false and misleading information, failing to disclose significant adverse impacts on free cash flow due to changes in vendor payment timing, resulting in investor losses once the truth emerged in the market.
- Law Firm's Advantage: Rosen Law Firm is renowned for its successful track record in securities class actions, having recovered over $438 million for investors in 2019 alone, highlighting its expertise and resource advantages in handling similar cases, which investors should consider when selecting legal counsel.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy STUB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on STUB
Wall Street analysts forecast STUB stock price to rise
13 Analyst Rating
8 Buy
5 Hold
0 Sell
Moderate Buy
Current: 6.100
Low
16.00
Averages
23.80
High
45.00
Current: 6.100
Low
16.00
Averages
23.80
High
45.00
About STUB
StubHub Holdings, Inc. operates a global secondary ticketing marketplace for live events. It connects fans around the world with sellers who use its marketplace to reach fans and price tickets efficiently. It operates its global ticketing marketplace through two brands: StubHub in North America and viagogo internationally. Its marketplace enables sellers of all types, including individual fans, professional sellers and content rights holders. Its technology is built to handle events regardless of their size, location, category or venue and includes end-to-end workflows and services that streamline the purchase and sale experience for buyers and sellers. It leverages its centralized technology and operations to reach buyers and sellers across the globe, supporting 33 languages and accepting payments in 48 currencies. Its marketplace is built to offer global distribution anywhere there is demand for live events. It offers data intelligence to optimize outcomes for buyers and sellers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
StubHub Partners with vivenu to Expand Ticketing Market Access
- Innovative Partnership Model: The collaboration between StubHub and vivenu provides event organizers with direct access to over 125 million fans globally, breaking traditional sales channel limitations and driving the future of ticket distribution.
- Seamless Integration Experience: Organizers can easily list tickets on StubHub through the vivenu platform, with automatic synchronization upon sale, streamlining ticket management processes and enhancing customer experience and sales efficiency.
- Expanded Market Coverage: Serving over 1,000 clients across more than 50 countries, including prestigious events like the Grammy Awards, vivenu's new integration allows its clients to leverage StubHub's extensive market reach without adding complexity.
- Data Control Assurance: This partnership ensures that organizers maintain full control over their data and operations while utilizing StubHub, aligning with modern ticketing market demands for data sovereignty.
See More
ULTRA Europe Partners with StubHub to Expand International Reach
- International Partnership: StubHub and viagogo announced a new Open Distribution partnership with ULTRA Europe, aimed at strengthening its international ticketing strategy, which is expected to attract more fans from around the globe and enhance the event's international presence.
- Market Coverage Expansion: StubHub will serve as ULTRA Europe's official distribution partner in North America, while viagogo will handle international markets outside North America, ensuring global fans have easier access to tickets, thereby driving ULTRA's globalization efforts.
- Enhanced Fan Experience: Every ticket purchased through StubHub and viagogo is backed by a fan guarantee, which boosts fan confidence when planning major live events and travel experiences, thus improving the overall ticketing experience.
- Star Lineup Announcement: The first phase lineup for ULTRA Europe 2026 has been announced, featuring renowned artists like Calvin Harris, with expectations to attract over 160,000 fans, further solidifying its status as a premier music festival in Europe.
See More
StubHub Launches Self-Serve Ticket Management Tool
- Tool Launch: StubHub's newly launched Distribution Manager is an AI-powered self-serve tool that allows artists, teams, and venues to list and manage official tickets directly on its global marketplace, reaching over 125 million fans and significantly enhancing ticket distribution efficiency.
- Sales Surge: More than 35 partners are already benefiting from StubHub's Open Distribution model, with direct integrated sales up 84% year-over-year, and one MLB team alone has sold over $40 million in tickets through the platform, indicating strong market demand.
- Simplified Operations: Distribution Manager requires no technical team or complex integration; users can simply type “Help me sell tickets,” and the system automatically lists inventory and sets sales goals, greatly lowering the usage barrier and enhancing user experience.
- Market Trend Alignment: As the market shifts towards open, non-exclusive distribution, Distribution Manager empowers rights holders with greater control, enabling them to connect directly with fans without seller-side fees, thereby strengthening StubHub's competitive position in the ticketing market.
See More
Iran's Sports Minister Announces Withdrawal from World Cup
- Iran's Decision: Iran will not participate in the 2026 FIFA World Cup.
- Reason for Withdrawal: The decision is attributed to the ongoing war in the Middle East, as stated by the country's sports minister.
See More
U.S. Justice Department Reaches Settlement with Live Nation
- Settlement Agreement: The U.S. Justice Department and Live Nation reached a tentative settlement allowing the company to retain ownership of Ticketmaster, concluding allegations of monopolistic behavior, although the agreement fell short of some competitors' expectations for a comprehensive overhaul.
- Exclusive Contract Restrictions: The settlement imposes limitations on Ticketmaster's ability to use exclusive ticketing contracts at venues it controls, aiming to foster competition from other ticketing companies, while still permitting exclusive agreements with other venues.
- Fee Cap Implementation: The agreement establishes a 15% cap on ancillary ticketing fees that Live Nation can charge at its venues and includes a $280 million settlement fund to reimburse allegedly harmed consumers, reflecting a commitment to consumer interests.
- Market Reaction: While the settlement is viewed as favorable for Live Nation, critics argue it fails to effectively address the company's market dominance, potentially leaving consumers to continue facing high ticketing costs.
See More
Relmada Therapeutics Shares Surge 40.8% on Promising Trial Data
- Market Decline: U.S. stocks fell broadly on Monday, with the Dow Jones index dropping around 650 points, indicating investor concerns about economic outlook which may impact consumer spending and overall market confidence.
- Relmada Stock Surge: Shares of Relmada Therapeutics Inc. soared 40.8% to $6.27 during Monday's session, driven by the release of promising interim data from its Phase 2 trial of NDV-01 for treating non-muscle invasive bladder cancer.
- Clinical Trial Results: The 12-month interim data revealed a complete response rate of 76%, with an impressive 80% in the BCG-unresponsive patient population, providing strong support for Relmada's treatment approach and potentially enhancing market acceptance.
- Positive Market Reaction: The favorable feedback from clinical data has led to optimistic investor sentiment regarding Relmada's future prospects, not only boosting the company's stock price but also likely attracting more investor interest in its ongoing research and development efforts.
See More
StubHub Partners with vivenu to Expand Ticketing Market Access
- Innovative Partnership Model: The collaboration between StubHub and vivenu provides event organizers with direct access to over 125 million fans globally, breaking traditional sales channel limitations and driving the future of ticket distribution.
- Seamless Integration Experience: Organizers can easily list tickets on StubHub through the vivenu platform, with automatic synchronization upon sale, streamlining ticket management processes and enhancing customer experience and sales efficiency.
- Expanded Market Coverage: Serving over 1,000 clients across more than 50 countries, including prestigious events like the Grammy Awards, vivenu's new integration allows its clients to leverage StubHub's extensive market reach without adding complexity.
- Data Control Assurance: This partnership ensures that organizers maintain full control over their data and operations while utilizing StubHub, aligning with modern ticketing market demands for data sovereignty.
See More
ULTRA Europe Partners with StubHub to Expand International Reach
- International Partnership: StubHub and viagogo announced a new Open Distribution partnership with ULTRA Europe, aimed at strengthening its international ticketing strategy, which is expected to attract more fans from around the globe and enhance the event's international presence.
- Market Coverage Expansion: StubHub will serve as ULTRA Europe's official distribution partner in North America, while viagogo will handle international markets outside North America, ensuring global fans have easier access to tickets, thereby driving ULTRA's globalization efforts.
- Enhanced Fan Experience: Every ticket purchased through StubHub and viagogo is backed by a fan guarantee, which boosts fan confidence when planning major live events and travel experiences, thus improving the overall ticketing experience.
- Star Lineup Announcement: The first phase lineup for ULTRA Europe 2026 has been announced, featuring renowned artists like Calvin Harris, with expectations to attract over 160,000 fans, further solidifying its status as a premier music festival in Europe.
See More
StubHub Launches Self-Serve Ticket Management Tool
- Tool Launch: StubHub's newly launched Distribution Manager is an AI-powered self-serve tool that allows artists, teams, and venues to list and manage official tickets directly on its global marketplace, reaching over 125 million fans and significantly enhancing ticket distribution efficiency.
- Sales Surge: More than 35 partners are already benefiting from StubHub's Open Distribution model, with direct integrated sales up 84% year-over-year, and one MLB team alone has sold over $40 million in tickets through the platform, indicating strong market demand.
- Simplified Operations: Distribution Manager requires no technical team or complex integration; users can simply type “Help me sell tickets,” and the system automatically lists inventory and sets sales goals, greatly lowering the usage barrier and enhancing user experience.
- Market Trend Alignment: As the market shifts towards open, non-exclusive distribution, Distribution Manager empowers rights holders with greater control, enabling them to connect directly with fans without seller-side fees, thereby strengthening StubHub's competitive position in the ticketing market.
See More
Iran's Sports Minister Announces Withdrawal from World Cup
- Iran's Decision: Iran will not participate in the 2026 FIFA World Cup.
- Reason for Withdrawal: The decision is attributed to the ongoing war in the Middle East, as stated by the country's sports minister.
See More
U.S. Justice Department Reaches Settlement with Live Nation
- Settlement Agreement: The U.S. Justice Department and Live Nation reached a tentative settlement allowing the company to retain ownership of Ticketmaster, concluding allegations of monopolistic behavior, although the agreement fell short of some competitors' expectations for a comprehensive overhaul.
- Exclusive Contract Restrictions: The settlement imposes limitations on Ticketmaster's ability to use exclusive ticketing contracts at venues it controls, aiming to foster competition from other ticketing companies, while still permitting exclusive agreements with other venues.
- Fee Cap Implementation: The agreement establishes a 15% cap on ancillary ticketing fees that Live Nation can charge at its venues and includes a $280 million settlement fund to reimburse allegedly harmed consumers, reflecting a commitment to consumer interests.
- Market Reaction: While the settlement is viewed as favorable for Live Nation, critics argue it fails to effectively address the company's market dominance, potentially leaving consumers to continue facing high ticketing costs.
See More
Relmada Therapeutics Shares Surge 40.8% on Promising Trial Data
- Market Decline: U.S. stocks fell broadly on Monday, with the Dow Jones index dropping around 650 points, indicating investor concerns about economic outlook which may impact consumer spending and overall market confidence.
- Relmada Stock Surge: Shares of Relmada Therapeutics Inc. soared 40.8% to $6.27 during Monday's session, driven by the release of promising interim data from its Phase 2 trial of NDV-01 for treating non-muscle invasive bladder cancer.
- Clinical Trial Results: The 12-month interim data revealed a complete response rate of 76%, with an impressive 80% in the BCG-unresponsive patient population, providing strong support for Relmada's treatment approach and potentially enhancing market acceptance.
- Positive Market Reaction: The favorable feedback from clinical data has led to optimistic investor sentiment regarding Relmada's future prospects, not only boosting the company's stock price but also likely attracting more investor interest in its ongoing research and development efforts.
See More
